InvestSMART

Global Health Limited (ASX:GLH)

ALERT: Price-sensitive ASX Announcement for GLH
Current share price for GLH : $0.065 -0.002 (-2.99%)+
Announcement
Release
25 Mar 2026 11:21AM
Price at Release
$0.067
Full Release
download
Summary
Global Health Limited (ASX: GLH) reported its Half-Year (HY) 2026 results, showcasing significant progress in its transformation into a SaaS-based company. The company's core operations achieved a pre-R&D operating profit of $478K, marking a pivot towards profitability despite a 40.5% reduction in R&D expenses. The company anticipates the completion of its SaaS platform transition by June 2026, which is expected to further improve EBITDA. Cash burn has dramatically decreased by 92% over two years, reinforcing GLH's strategy of self-funded growth without the need for additional capital raises. The company's revenue is now 92% recurring, setting a strong foundation for future growth. Key initiatives include partnerships with Best Practice, AI integrations, and the commercialization of Lifecard, enhancing its market position and expanding its addressable market.
Key Points
  • Core operations profitable at $478K pre-R&D.
  • R&D expenses reduced by 40.5% as SaaS transition nears completion.
  • Cash burn reduced by 92% over two years.
  • 92% of revenue is recurring, indicating high-quality revenue base.
  • SaaS platform transition to be completed by June 2026.
  • Partnerships with Best Practice and AI integrations enhance market position.
  • No plans for capital raises; operating within internally generated cash flow.
  • Forecast FY26 customer revenue approximately $7.5M.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.